Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Meco

Showing results (11-20 of 117) with videos related to

Pageof 12
Sort By:
Bollettino Della Societa Italiana Di Biologia Sperimentale|April 30, 1978
[Effect of phosphodiesterase inhibitors on neuroleptic-induced catalepsy and apomorphine-induced stereotypic movements in rats]R Cerbo, F Carchedi, M Casacchia, et al.
Acta Neurologica|July 1, 1976
[MIF (melanocyte-stimulating hormone release-inhibiting factor) and Parkinson's disease]A Carolei, G Meco, M Casacchia, et al.
Acta Neurologica|May 1, 1976
[Directed therapy of Parkinson's disease. Clinical evaluations and pharmacological choice]M Casacchia, G Meco, S Fabri, et al.
Lancet (London, England)|May 28, 1994
Risperidone for hallucinations in levodopa-treated Parkinson's disease patientsG Meco, A Alessandria, V Bonifati, et al.
Acta Neurologica Scandinavica|March 1, 1991
Hypothalamo-pituitary function and dopamine dependence in untreated parkinsonian patientsG Cusimano, C Capriani, V Bonifati, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 1, 1997
Cognitive improvement during Tolcapone treatment in Parkinson's diseaseM Gasparini, E Fabrizio, V Bonifati, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 1997
Risperidone in levodopa-induced psychosis in advanced Parkinson's disease: an open-label, long-term studyG Meco, A Alessandri, P Giustini, et al.
Scandinavian Journal of Work, Environment & Health|August 1, 1994
Parkinsonism after chronic exposure to the fungicide maneb (manganese ethylene-bis-dithiocarbamate)G Meco, V Bonifati, N Vanacore, et al.
Rivista Di Neurologia|July 1, 1975
[Treatment of anxiety in Parkinson's disease with bromazepam]M Casacchia, A Zamponi, G Squitieri, et al.
Acta Neurologica|July 1, 1976
[CB 154 in the treatment of Parkinson's disease. Results in combination with L-dopa and decarboxylase inhibitor]G Meco, M Casacchia, A Zamponi, et al.
Pageof 12

Showing results (11-20 of 117) with videos related to

Sort By:
Pageof 12
Bollettino Della Societa Italiana Di Biologia Sperimentale|April 30, 1978
[Effect of phosphodiesterase inhibitors on neuroleptic-induced catalepsy and apomorphine-induced stereotypic movements in rats]R Cerbo, F Carchedi, M Casacchia, et al.
Acta Neurologica|July 1, 1976
[MIF (melanocyte-stimulating hormone release-inhibiting factor) and Parkinson's disease]A Carolei, G Meco, M Casacchia, et al.
Acta Neurologica|May 1, 1976
[Directed therapy of Parkinson's disease. Clinical evaluations and pharmacological choice]M Casacchia, G Meco, S Fabri, et al.
Lancet (London, England)|May 28, 1994
Risperidone for hallucinations in levodopa-treated Parkinson's disease patientsG Meco, A Alessandria, V Bonifati, et al.
Acta Neurologica Scandinavica|March 1, 1991
Hypothalamo-pituitary function and dopamine dependence in untreated parkinsonian patientsG Cusimano, C Capriani, V Bonifati, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 1, 1997
Cognitive improvement during Tolcapone treatment in Parkinson's diseaseM Gasparini, E Fabrizio, V Bonifati, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|July 1, 1997
Risperidone in levodopa-induced psychosis in advanced Parkinson's disease: an open-label, long-term studyG Meco, A Alessandri, P Giustini, et al.
Scandinavian Journal of Work, Environment & Health|August 1, 1994
Parkinsonism after chronic exposure to the fungicide maneb (manganese ethylene-bis-dithiocarbamate)G Meco, V Bonifati, N Vanacore, et al.
Rivista Di Neurologia|July 1, 1975
[Treatment of anxiety in Parkinson's disease with bromazepam]M Casacchia, A Zamponi, G Squitieri, et al.
Acta Neurologica|July 1, 1976
[CB 154 in the treatment of Parkinson's disease. Results in combination with L-dopa and decarboxylase inhibitor]G Meco, M Casacchia, A Zamponi, et al.
Pageof 12